IL1B and neoplasm: Furthermore, mobilized N1-TANs can differentiate into antigen-presenting cells by expressing MHC class I and class II molecular T cells and activate Th17, CD8 T, proliferating Τ, and NK cells in cytokine signaling pathways via IL1B, thereby amplifying anti-tumor immunity.